|
rs1217691063
|
|
|
0.020 |
GeneticVariation |
BEFREE |
According to our results, the C677T mutation does not constitute a major risk factor for transient ischemic attack or minor stroke, even under consideration of other possibly confounding factors that are known to affect plasma homocysteine levels.
|
10360632 |
1999 |
|
rs1217691063
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We investigated the prevalence of both the C677T MTHFR mutation and the factor V Leiden mutation in 81 patients with transient ischemic attack (TIA) or minor stroke (MS) and in 81 age- and sex-matched control subjects free from clinically manifest vascular disease.
|
9950259 |
1999 |
|
rs1042522
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our findings demonstrate that the Tp53 Arg72Pro SNP controls PC-promoted neuroprotection against a subsequent ischemic insult by modulating mitochondrial p53 stabilization and then modulates TIA-induced ischemic tolerance.
|
29687302 |
2019 |
|
rs1057335
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We investigated associations of α2AP Arg407Lys polymorphism with cryptogenic IS and TIA.
|
29306602 |
2019 |
|
rs1131691014
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our findings demonstrate that the Tp53 Arg72Pro SNP controls PC-promoted neuroprotection against a subsequent ischemic insult by modulating mitochondrial p53 stabilization and then modulates TIA-induced ischemic tolerance.
|
29687302 |
2019 |
|
rs1353702185
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our findings demonstrate that the Tp53 Arg72Pro SNP controls PC-promoted neuroprotection against a subsequent ischemic insult by modulating mitochondrial p53 stabilization and then modulates TIA-induced ischemic tolerance.
|
29687302 |
2019 |
|
rs878854066
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our findings demonstrate that the Tp53 Arg72Pro SNP controls PC-promoted neuroprotection against a subsequent ischemic insult by modulating mitochondrial p53 stabilization and then modulates TIA-induced ischemic tolerance.
|
29687302 |
2019 |
|
rs121918632
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Her symptoms were first suspicious of a transient ischemic attack (TIA), but they were eventually diagnosed as FHM with a c.4495T>C mutation being found in the <i>SCN1A</i> gene.
|
30498473 |
2018 |
|
rs28935197
|
|
|
0.010 |
GeneticVariation |
BEFREE |
N215S patients showed later symptom onset (males: p< 0.0001, females: p<0.03), later development of left ventricular hypertrophy (LVH) (median survival without LVH: 41 (non-N215S) vs. 64 (N215S) years, p< 0.0001), later development of proteinuria (median survival without proteinuria 43 (non-N215S) vs 71 years (N215S), p< 0.0001), later occurrence of cerebrovascular events (stroke/ Transient Ischaemic Attacks (TIA); median survival without stroke: 74 years (non-N215S) vs. not reached (N215S), p< 0.02), later decline in renal function to GFR <60 ml/min/1.73m2 (median survival: 56 (non-N215S) vs. 72 (N215S) years, p< 0.01), and greater overall survival (median survival 81 (N215S) vs. 66 (non-N215S) years, p< 0.0006).
|
29621274 |
2018 |
|
rs799454
|
|
|
0.010 |
GeneticVariation |
BEFREE |
An <i>SRP54-AS1</i> risk allele, rs799454(G) was associated with stroke/transient ischaemic attack in SLE (OR 1.7 (1.3 to 2.2), P=2.5×10<sup>-5</sup>) but not in RA.
|
29514802 |
2018 |
|
rs104894845
|
|
|
0.010 |
GeneticVariation |
BEFREE |
No accumulation of neurologic events in family members of p.A143T </span>patients with stroke/transient ischemic attacks was observed.
|
27142856 |
2016 |
|
rs2071410
|
|
|
0.010 |
GeneticVariation |
BEFREE |
CONCLUSIONS Furin rs2071410 was significantly correlated with TIA occurrence and prognosis in the Chinese population.
|
27760099 |
2016 |
|
rs397507444
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Cerebral venous sinus thrombosis presenting as transient ischemic attacks in a case with homozygous mutations of MTHFR A1298C and CG677T.
|
20833086 |
2012 |
|
rs17782313
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The odds ratios for stroke/TIA were 1.14 (95%CI 0.91-1.42) for rs9937053/FTO, 1.11 (95%CI 0.49-2.51) for rs2229616/MC4R, 1.05 (95%CI 0.82-1.3) for rs17782313/MC4R, and 0.99 (95%CI 0.78-1.25) for rs7903146/TCF7L2.
|
21921652 |
2011 |
|
rs2229616
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The odds ratios for stroke/TIA were 1.14 (95%CI 0.91-1.42) for rs9937053/FTO, 1.11 (95%CI 0.49-2.51) for rs2229616/MC4R, 1.05 (95%CI 0.82-1.3) for rs17782313/MC4R, and 0.99 (95%CI 0.78-1.25) for rs7903146/TCF7L2.
|
21921652 |
2011 |
|
rs7903146
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The observed trends of obesity risk alleles for risk of stroke/TIA as well as the possible sex-specific differences in clinical outcomes found for the TCF7L2 (rs7903146) require replication in future studies.
|
21921652 |
2011 |
|
rs9937053
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The odds ratios for stroke/TIA were 1.14 (95%CI 0.91-1.42) for rs9937053/FTO, 1.11 (95%CI 0.49-2.51) for rs2229616/MC4R, 1.05 (95%CI 0.82-1.3) for rs17782313/MC4R, and 0.99 (95%CI 0.78-1.25) for rs7903146/TCF7L2.
|
21921652 |
2011 |